# Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male Volunteers

> **NCT01679613** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 34 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nintedanib
- **DRUG:** Nintedanib
- **DRUG:** Ketoconazole
- **DRUG:** Nintedanib
- **DRUG:** Nintedanib
- **DRUG:** Ketoconazole

## Key facts

- **NCT ID:** NCT01679613
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2014-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01679613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01679613, "Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01679613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*